Clinical Trials
5
Trial Phases
3 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (5 trials with phase data)• Click on a phase to view related trials
Kesuting Syrup in the Treatment of Corona Virus Disease 2019 (COVID-19)
- Conditions
- COVID-19 PneumoniaCough
- Interventions
- Drug: LianHuaQingWen GranulesDrug: Kesuting syrup
- First Posted Date
- 2022-05-09
- Last Posted Date
- 2022-09-19
- Lead Sponsor
- Guizhou Bailing Group Pharmaceutical Co Ltd
- Target Recruit Count
- 200
- Registration Number
- NCT05366231
- Locations
- 🇨🇳
Shanghai Public Health Clinical Center, Shanghai, Shanghai, China
Tangningtongluo Tablet in the Treatment of Non-proliferative Diabetic Retinopathy
- Conditions
- Type2 DiabetesDiabetic Retinopathy
- Interventions
- Drug: Tangningtongluo tablets
- First Posted Date
- 2021-08-16
- Last Posted Date
- 2023-05-09
- Lead Sponsor
- Guizhou Bailing Group Pharmaceutical Co Ltd
- Target Recruit Count
- 240
- Registration Number
- NCT05007262
- Locations
- 🇨🇳
Chongqing hospital of traditional Chinese Medicine, Chongqing, Chongqing, China
🇨🇳Gansu Provincial Hospital of traditional Chinese Medicine, Lanzhou, Gansu, China
🇨🇳People's Hospital of Anshun City Guizhou Province, Anshun, Guizhou, China
Multi-center Clinical Study of Guli Capsules in the Treatment of Knee Osteoarthritis
- Conditions
- Knee Osteoarthritis
- Interventions
- Drug: Guli capsuleDrug: Kangguzengsheng capsule
- First Posted Date
- 2015-06-29
- Last Posted Date
- 2015-06-29
- Lead Sponsor
- Guizhou Bailing Group Pharmaceutical Co Ltd
- Target Recruit Count
- 220
- Registration Number
- NCT02484508
- Locations
- 🇨🇳
Wangjing Hospital, Chinese Academy of Traditional Chinese Medicine, Beijing, Beijing, China
The Effect of Tang Ning Tongluo Formula in Type 2 Diabetics Clinical Analysis
- Conditions
- General Disorders and Administration Site Conditions
- Interventions
- Drug: Tangning Tongluo Capsule
- First Posted Date
- 2014-06-25
- Last Posted Date
- 2014-09-11
- Lead Sponsor
- Guizhou Bailing Group Pharmaceutical Co Ltd
- Target Recruit Count
- 120
- Registration Number
- NCT02174042
- Locations
- 🇨🇳
Nanmeng Tianyuan hospital; Dongfang Hospital; China-Japanese Friendship Hospital, Beijing Shi, Guizhou, China
Clinical Trials for the Optimal Dosage of Tang Ning Tongluo Capsule
- Conditions
- Accidental Exposure While Preparing Drug for Administration
- Interventions
- Drug: TNTL capsuleDrug: Placebo
- First Posted Date
- 2014-06-11
- Last Posted Date
- 2014-09-11
- Lead Sponsor
- Guizhou Bailing Group Pharmaceutical Co Ltd
- Target Recruit Count
- 110
- Registration Number
- NCT02161276
- Locations
- 🇨🇳
Tianyuan Hospital of Guiyang City, Guiyang, Guizhou, China